The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

PharmaCyte Biotech, Inc. insider acquisitions

Company CIK 0001157075 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
PMCB · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 24, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.WEINSTEIN ROBERTWEINSTEIN ROBERTWALKER WAYNE REMELLWALKER WAYNE REMELLSilverman JoshuaSilverman JoshuaSCHECHTER JONATHANSCHECHTER JONATHANAbecassis Michael MAbecassis Michael MWEINSTEIN ROBERT · April 25, 2025 · Stock award · Stock Option (Right to Buy)WEINSTEIN ROBERT · December 12, 2025 · Stock award · Common StockWALKER WAYNE REMELL · April 25, 2025 · Stock award · Stock Option (Right to Buy)WALKER WAYNE REMELL · December 12, 2025 · Stock award · Common StockSilverman Joshua · December 12, 2025 · Stock award · Common StockSCHECHTER JONATHAN · April 25, 2025 · Stock award · Stock Option (Right to Buy)SCHECHTER JONATHAN · December 12, 2025 · Stock award · Common StockAbecassis Michael M · April 25, 2025 · Stock award · Stock Option (Right to Buy)Abecassis Michael M · December 12, 2025 · Stock award · Common StockApr 25, 2025Dec 12, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Apr 25, 2025PharmaCyte Biotech, Inc.Stock Option (Right to Buy)WEINSTEIN ROBERTStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockWEINSTEIN ROBERTStock award
Apr 25, 2025PharmaCyte Biotech, Inc.Stock Option (Right to Buy)WALKER WAYNE REMELLStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockWALKER WAYNE REMELLStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockSilverman JoshuaStock award
Apr 25, 2025PharmaCyte Biotech, Inc.Stock Option (Right to Buy)SCHECHTER JONATHANStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockSCHECHTER JONATHANStock award
Apr 25, 2025PharmaCyte Biotech, Inc.Stock Option (Right to Buy)Abecassis Michael MStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockAbecassis Michael MStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

PMCB · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A63,2330Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A75,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A63,2330Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A37,5000Value: 0Currency not specifiedView ↗
Trade:
Silverman JoshuaCEO and President · Director
Stock awardCommon StockNon-derivative security · Code A575,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A63,2330Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (Right to Buy)Derivative security · Code A63,2330Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A37,5000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →